IP Library Granted Patent US 11,299,715
Granted Patent B2
US 11,299,715 · App. 14/758,785 · Granted Apr 12, 2022

Use of iNOS inhibitors to increase viral yield in culture

Inventors: Peter Pechan (Cambridge, MA); Jeffery Ardinger (Canbridge, MA); Abraham Scaria (Cambridge, MA); Samuel Wadsworth (Cambridge, MA)
Assignee: Genzyme Corporation
C12N7/00C12N2710/16643C12N2710/16651
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,299,715
App. No.
14/758,785
Granted
Apr 12, 2022
Kind
B2
Abstract

The use of iNOS inhibitors, including aurintricarboxylic acid, dexamethasone and valproic acid, to increase the yield of a variety of viruses in culture, including recombinant herpesviruses is described.

Claims (11)

1. A method for producing herpes simplex-1 virus (HSV-1) comprising culturing cells infected with said herpes simplex-1 virus in a cell culture medium that comprises aurintricarboxylic acid and serum, wherein the aurintricarboxylic acid is unfractionated, wherein aurintricarboxylic acid is at a concentration of about 5 μM to about 75 μM, and wherein the cells are 293 or Vero cells.

2. The method of claim 1 , wherein said HSV-1 is a wild type HSV-1.

3. The method of claim 1 , wherein said HSV-1 is a recombinant HSV-1 .

4. The method of claim 3 , wherein said recombinant HSV-1 is HSV-1 d27.1.

5. The method of claim 1 , wherein said Vero cells are V27 cells.

6. A method for producing HSV-1 d27.1 comprising:

(a) infecting V27 cells with said HSV-1 d27.1; and

(b) culturing said infected V27 cells in a cell culture medium comprising serum, and aurintricarboxylic acid, wherein aurintricarboxylic acid is at a concentration of about 5 μM to about 75 μM, and wherein aurintricarboxylic acid is unfractionated.

7. The method of claim 6 , wherein the serum is fetal bovine serum.

8. A cell culture comprising aurintricarboxylic acid, serum and 293 or Vero cells infected with HSV-1, wherein aurintricarboxylic acid is unfractionated, wherein aurintricarboxylic acid is at a concentration of about 5 μM to about 75 μM.

9. The cell culture of claim 8 wherein said Vero cells are V27 cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 23, 2018
From: PECHAN, PETER; ARDINGER, JEFFERY; SCARIA, ABRAHAM; WADSWORTH, SAMUEL
To: GENZYME CORPORATION
Reel/Frame 044706/0171 →
Continuity (2)
Provisional Application 61750175 · Jan 8, 2013
Related Publication 20150353899A1 · Dec 10, 2015